Charter Oak Capital Management’s Novartis NVS Stock Holding History

Charter Oak Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Buy	+1,360	New	+$208K	0.02%	201
2022 Q3	–	Sell	-1,042	Closed	-$88K	–	630
2022 Q2	$88K	Hold	1,042	–	–	0.01%	259
2022 Q1	$91K	Buy	1,042 +7	+0.7%	+$606	0.01%	272
2021 Q4	$91K	Sell	1,035 -113	-10%	-$9.38K	0.01%	269
2021 Q3	$94K	Buy	1,148 +18	+2%	+$1.62K	0.01%	255
2021 Q2	$103K	Sell	1,130 -25	-2%	-$2.23K	0.01%	236
2021 Q1	$99K	Buy	1,155 +7	+0.6%	+$628	0.01%	240
2020 Q4	$108K	Buy	+1,148	New	+$100K	0.02%	218

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charter Oak Capital Management's NVS Position: Q1 2026 in Review

Charter Oak Capital Management opened a new position in Novartis (NVS) in Q1 2026: 1,360 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #201 among its holdings. This is a return to the name: Charter Oak Capital Management previously reported a position in NVS as recently as Q2 2022.

Charter Oak Capital Management first reported a position in NVS in Q4 2020 and has held it in 8 quarters since. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Charter Oak Capital Management held 1,360 shares of Novartis worth $208K as of Q1 2026.
Novartis was a new Charter Oak Capital Management position in Q1 2026.
Novartis made up 0.02% of Charter Oak Capital Management's portfolio in Q1 2026, its #201 holding.
Charter Oak Capital Management first reported a position in Novartis in Q4 2020 and has held it in 8 quarters since.
1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.